ZEISS Group appoints Axel Christian as President of ZEISS North America
New role reflects the enduring and growing strategic significance of the region for ZEISS' long-term roadmap.Christian will represent ZEISS North America,...
Vaccine
Ask a CVS Pharmacist: Your Top Flu Shot Questions, Answered
WOONSOCKET, RI / ACCESS Newswire / October 1, 2026 / CVS HealthOriginally published on CVS Health Company NewsroomCVS Pharmacy pharmacists...
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
Juan Andres to Return to Moderna as Chief Operating OfficerJerh Collins to Retire Following Four Years of Leadership at Moderna...
Prepping for Fall: It Is Time for Everyone to Get Their Annual Respiratory Virus Vaccines
American Lung Association launches campaign to educate people living with lung disease and other risk factors about critical vaccines CHICAGO,...
Rabies Prevention: From Ancient Fear to Modern Solutions
Rabies claims tens of thousands of lives each year, even though tools to eliminate it exist: A conversation with Dr....
Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
SHELTON, CT / ACCESS Newswire / September 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
2026 Collegiate Inventors Competition Finalists Showcase Future of American Innovation
NORTH CANTON, Ohio, Sept. 24, 2026 /PRNewswire/ -- The Collegiate Inventors Competition®, an annual competition that has rewarded innovations, discoveries...
Assort Health Scales Across Primary Care, Now Partnering With Over 1,300 Providers
Assort resolves 95% of patient interactions that don't require staff handoff, giving practices the proof they need to bring AI...
Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
SHELTON, CT / ACCESS Newswire / September 23, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that the...
Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026
Phase 3 data for intismeran autogene in the adjuvant treatment of patients with resected stage IIB-IV melanoma selected for presentation...
Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides
SHELTON, CT / ACCESS Newswire / September 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
PSMA Connect and HealthIQ Solutions Form Strategic Healthcare Alliance to Drive Cost Savings, Clinical Innovation, and Sustainable Provider Revenue
Landmark partnership combines nationwide group purchasing power with advanced remote patient care programs to expand healthcare access across urban and...
Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults
Phase 3 study demonstrates benefits of the first influenza vaccine to combine three proven approaches to enhancing protection for older...
Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic Across the U.S.
Appointments can be scheduled through the CVS Health app or CVS.com and walk-ins are acceptedOriginally published on CVS Health Company...
Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation
Enhanced Board and leadership team, including the appointment of a new Chief Medical Officer, strengthens governance, execution and clinical capabilitiesSAN...
Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo
SHELTON, CT / ACCESS Newswire / September 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Back-to-School Health Checklist: What Parents Can Do To Help Kids Start the School Year Strong
Originally published on CVS Health Company Newsroom WOONSOCKET, RI / ACCESS Newswire / September 3, 2026 / As summer winds...
Moderna to Present at Upcoming Conferences in September 2026
CAMBRIDGE, MA / ACCESS Newswire / September 1, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following...
Boehringer Ingelheim launches SCOVELLA® in Great Britain, the first approved therapy for insulin dysregulation in horses, a main cause of laminitis
Boehringer headquarters Ingelheim, Germany Ingelheim, Germany, and Bracknell, United Kingdom SCOVELLA® is the first therapy specifically developed and approved for...
While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles
SHELTON, CT / ACCESS Newswire / August 31, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"),...
